Valvular & structural heart disease

Incidence, causes, correlates, and outcome of bioprosthetic valve dysfunction and failure following transcatheter aortic valve implantation

Eur Heart J Cardiovasc ImagingPublished Prospective cohort study

Authors' conclusion

In this large prospective observational cohort, early to mid-term BVD after TAVI occurred at the same rate across the spectrum of life expectancy and was associated with increased mortality in patients with short but not in those with the longest life expectancy.

Study context

Population
Consecutive transcatheter aortic valve implantation (TAVI) recipients (2007–20) with follow-up ≥1 year622 serial echo cohort
Participants
1,047 recipients
Exposure
Life expectancy tertiles
Outcome
BVD/BVF (VARC-3) and all-cause death
Methodological detailsconsecutive patients
  • Consecutive patients

Main finding

As reported in the abstract

Incidence of BVD/BVF · median echo follow-up 12.2 months

Bioprosthetic valve dysfunction (BVD) incidence per valve-year

8.4%

95% CI 6.7–10.3

BVF incidence per valve-year (2.5-4.9)

3.5%

Observational data: associations, not effects.

Further findings

Association of BVD/BVF with outcome, by life expectancy tertile

Adjusted HR (CI)
1st tertileBVD1.72 (1.06–2.88)
1st tertileBVF2.97 (1.72–6.22)
2nd tertileBVD1.96 (1.02–3.73)
2nd tertileBVF2.31 (1.00–5.30)
OutcomeP value
Association of BVD/BVF with outcome, by life expectancy tertile3rd tertile · not associatedP = n.s.

BVD incidence by time since implant

Within first year, per valve-year
9.9%
Beyond first year, per valve-year
4.8%

Correlates of BVD

Valve-in-valve procedure and residual stenosis, but not age/life expectancy, predisposed for BVD

Original publication

Incidence, causes, correlates, and outcome of bioprosthetic valve dysfunction and failure following transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging. Published 13 September 2022. doi:10.1093/ehjci/jeac188

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.